Genetic-molecular study of the egfr/ pi3k/akt pathway in high and low grade gliomas
Gliomas account for 70% of all central nervous system (CNS) tumors and are classified according to the WHO in low (I and II) or high (III and IV or glioblastoma multiforme, GBM) grade malignancies. The survival of patients with a high grade is less than 2 years. The EGFR/PI3K/AKT pathway promotes ce...
Autores Principales: | , , , , , |
---|---|
Formato: | Objeto de conferencia (Conference Object) |
Lenguaje: | Inglés (English) |
Publicado: |
Elsevier
2010
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/26484 https://doi.org/10.1016/j.cancergencyto.2010.07.077 |